Tempus AI pulling, refiling US antitrust paperwork for Personalis buyout
MLex Summary: Health technology company Tempus AI withdrew the US federal premerger antitrust form for its proposed acquisition of cancer diagnostics firm Personalis on Aug. 31, and the company intends to...To view the full article, register now.
Already a subscriber? Click here to view full article